{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:30:20Z","timestamp":1774945820422,"version":"3.50.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.it.2020.11.003","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T08:56:19Z","timestamp":1605257779000},"page":"31-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Combining Antivirals and Immunomodulators to Fight COVID-19"],"prefix":"10.1016","volume":"42","author":[{"given":"Vincent","family":"Feuillet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Canard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2020.11.003_bb0005","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.it.2020.11.003_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.it.2020.11.003_bb0020","doi-asserted-by":"crossref","first-page":"11620","DOI":"10.1128\/JVI.00702-07","article-title":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain","volume":"81","author":"Wathelet","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/JVI.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.it.2020.11.003_bb0035","doi-asserted-by":"crossref","first-page":"17554","DOI":"10.1038\/srep17554","article-title":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets","volume":"5","author":"Yang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.it.2020.11.003_bb0040","doi-asserted-by":"crossref","first-page":"16202","DOI":"10.1074\/jbc.M109.008227","article-title":"Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3\u00b7TANK\u00b7TBK1\/IKK\u03f5 complex","volume":"284","author":"Siu","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2020.11.003_bb0045","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/med.21664","article-title":"Medicinal chemistry strategies toward host targeting antiviral agents","volume":"40","author":"Ji","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.it.2020.11.003_bb0050","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.it.2020.11.003_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.it.2020.11.003_bb0060","doi-asserted-by":"crossref","first-page":"104793","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.it.2020.11.003_bb0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.it.2020.11.003_bb0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.it.2020.11.003_bb0080","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-020-18463-z","article-title":"Rapid incorporation of favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis","volume":"11","author":"Shannon","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2020.11.003_bb0085","doi-asserted-by":"crossref","first-page":"112527","DOI":"10.1016\/j.ejmech.2020.112527","article-title":"A promising antiviral candidate drug for the COVID-19 pandemic: a mini-review of remdesivir","volume":"201","author":"Liang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.it.2020.11.003_bb0090","article-title":"Repurposed antiviral drugs for COVID-19 \u2013interim WHO SOLIDARITY trial results","author":"WHO Solidarity Trial Consortium, W.S. trial et al","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.it.2020.11.003_bb0095","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1128\/MCB.26.5.1888-1897.2006","article-title":"Inquiring into the differential action of interferons (IFNs): an IFN-\u03b12 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-\u03b2","volume":"26","author":"Jaitin","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.it.2020.11.003_bb0100","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1073\/pnas.76.4.1824","article-title":"Fibroblast interferon induces synthesis of four proteins in human fibroblast cells","volume":"76","author":"Knight","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2020.11.003_bb0105","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1073\/pnas.81.21.6733","article-title":"Transcriptional induction of two genes in human cells by beta interferon","volume":"81","author":"Larner","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2020.11.003_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2009.05152.x","article-title":"Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses","volume":"1183","author":"Lande","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.it.2020.11.003_bb0115","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chom.2017.07.012","article-title":"Ten strategies of interferon evasion by viruses","volume":"22","author":"Garc\u00eda-Sastre","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2020.11.003_bb0120","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of interferon signaling by dengue virus","volume":"100","author":"Mu\u00f1oz-Jordan","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2020.11.003_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Coronaviruses"},{"key":"10.1016\/j.it.2020.11.003_bb0130","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0135","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1128\/JVI.03496-12","article-title":"Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus","volume":"87","author":"Zielecki","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0140","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.it.2020.11.003_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0060226","article-title":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum","volume":"6","author":"Knoops","year":"2008","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2020.11.003_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01658-17","article-title":"Expression and cleavage of Middle East respiratory syndrome coronavirus nsp3\u20134 polyprotein induce the formation of double-membrane vesicles that mimic those associated with coronaviral RNA replication","volume":"8","author":"Oudshoorn","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.it.2020.11.003_bb0155","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02143-16","article-title":"The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination","volume":"91","author":"Hu","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0160","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1128\/JVI.03649-13","article-title":"Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response","volume":"88","author":"Siu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0165","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/pmic.201200225","article-title":"Correlation between TGF-\u03b21 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain-like protease","volume":"12","author":"Li","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.it.2020.11.003_bb0170","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.4049\/jimmunol.172.12.7841","article-title":"Altered p38 mitogen-activated protein kinase expression in different leukocytes with increment of immunosuppressive mediators in patients with severe acute respiratory syndrome","volume":"172","author":"Lee","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2020.11.003_bb0175","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41418-020-0572-6","article-title":"Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)","volume":"27","author":"Agrati","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.it.2020.11.003_bb0180","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1038\/s41467-019-11998-w","article-title":"TGF\u03b2 blocks IFN\u03b1\/\u03b2 release and tumor rejection in spontaneous mammary tumors","volume":"10","author":"Guerin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2020.11.003_bb0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50740","article-title":"Preclinical murine tumor models: a structural and functional perspective","volume":"9","author":"Guerin","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.it.2020.11.003_bb0190","doi-asserted-by":"crossref","first-page":"52294","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.it.2020.11.003_bb0195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1749-6632.1993.tb35912.x","article-title":"TGF beta and HIV infection","volume":"685","author":"Lotz","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.it.2020.11.003_bb0200","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1042\/CS20160218","article-title":"1,8-Cineole potentiates IRF3-mediated antiviral response in human stem cells and in an ex vivo model of rhinosinusitis","volume":"130","author":"M\u00fcller","year":"2016","journal-title":"Clin. Sci."},{"key":"10.1016\/j.it.2020.11.003_bb0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/14740338.2011.559161","article-title":"Pegylated-interferon-\u03b12a in clinical practice: how to manage patients suffering from side effects","volume":"10","author":"Calvaruso","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.it.2020.11.003_bb0210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.it.2020.11.003_bb0215","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.it.2020.11.003_bb0220","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.virol.2015.08.010","article-title":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome","volume":"485","author":"Nieto-Torres","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.it.2020.11.003_bb0225","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fmicb.2019.00050","article-title":"Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.it.2020.11.003_bb0230","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.it.2020.11.003_bb0235","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. an evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.it.2020.11.003_bb0240","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0245","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/eji.1830230950","article-title":"Increased cytokine production in mononuclear cells of healthy elderly people","volume":"23","author":"Fagiolo","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2020.11.003_bb0250","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1043-4666(03)00152-2","article-title":"Serum IL-1\u03b2 levels in health and disease: a population-based study. \u201cThe InCHIANTI study\u201d","volume":"22","author":"Di Iorio","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.it.2020.11.003_bb0255","article-title":"OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.it.2020.11.003_bb0260","article-title":"Inflamm-aging: why older men are the most susceptible to SARS-Cov-2 complicated outcomes","author":"Bonaf\u00e8","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.it.2020.11.003_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000756","article-title":"Exacerbated innate host response to SARS-CoV in aged non-human primates","volume":"6","author":"Smits","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.it.2020.11.003_bb0270","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","article-title":"Age- and gender-related difference of ACE2 expression in rat lung","volume":"78","author":"Xudong","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.it.2020.11.003_bb0275","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2020.11.003_bb0280","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijid.2013.12.003","article-title":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study","volume":"20","author":"Al-Tawfiq","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0285","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.biochi.2007.04.016","article-title":"Human primary immunodeficiencies of type I interferons","volume":"89","author":"Jouanguy","year":"2007","journal-title":"Biochimie"},{"key":"10.1016\/j.it.2020.11.003_bb0290","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.it.2020.11.003_bb0295","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0300","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1172\/JCI0211198","article-title":"Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes","volume":"109","author":"Horwitz","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2020.11.003_bb0305","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","article-title":"On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis","volume":"111","author":"Hadinoto","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2020.11.003_bb0310","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI10209","article-title":"EBNA1-specific CD4+ T cells in healthy carriers of Epstein\u2013Barr virus are primarily Th1 in function","volume":"107","author":"Bickham","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2020.11.003_bb0315","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/eji.200425548","article-title":"Contemporaneous fluctuations in T cell responses to persistent herpes virus infections","volume":"35","author":"Crough","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2020.11.003_bb0320","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/blood.V98.1.146","article-title":"Dysfunctional Epstein\u2013Barr virus (EBV)-specific CD8+ T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma","volume":"98","author":"van Baarle","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.it.2020.11.003_bb0325","series-title":"Fields Virology","first-page":"2343","article-title":"Epstein\u2013Barr virus and its replication","author":"Kieff","year":"1996"},{"key":"10.1016\/j.it.2020.11.003_bb0330","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12916-020-01529-6","article-title":"Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection","volume":"18","author":"Muema","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.it.2020.11.003_bb0335","first-page":"3544","article-title":"Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response","volume":"119","author":"Jacquelin","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2020.11.003_bb0340","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1128\/JVI.02612-09","article-title":"Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques","volume":"84","author":"Harris","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000395511","article-title":"Virus infections in bats","volume":"8","author":"Sulkin","year":"1974","journal-title":"Monogr. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3161\/15081109ACC2017.19.2.001","article-title":"A potent anti-inflammatory response in bat macrophages may be linked to extended longevity and viral tolerance","volume":"19","author":"Kacprzyk","year":"2017","journal-title":"Acta Chiropterolog."},{"key":"10.1016\/j.it.2020.11.003_bb0355","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tim.2014.12.004","article-title":"Bats as \u2018special\u2019 reservoirs for emerging zoonotic pathogens","volume":"23","author":"Brook","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.it.2020.11.003_bb0360","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00281-017-0625-1","article-title":"Immune-mediated cytokine storm and its role in severe dengue","volume":"39","author":"Srikiatkhachorn","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.it.2020.11.003_bb0365","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/jir.2017.0037","article-title":"Highlights for dengue immunopathogenesis: antibody-dependent enhancement, cytokine storm, and beyond","volume":"38","author":"Kuczera","year":"2018","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.it.2020.11.003_bb0370","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"McHutchison","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0375","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0380","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01061-20","article-title":"A randomized clinical trial of the efficacy and safety of interferon \u03b2-1a in treatment of severe COVID-19","volume":"64","author":"Davoudi-Monfared","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.it.2020.11.003_bb0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.antiviral.2014.12.011","article-title":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus","volume":"115","author":"Cheng","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.it.2020.11.003_bb0390","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2020.11.003_bb0395","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaci.2005.09.017","article-title":"Activin A is an acute allergen-responsive cytokine and provides a link to TGF-\u03b2-mediated airway remodeling in asthma","volume":"117","author":"Karagiannidis","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.it.2020.11.003_bb0400","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cyto.2014.10.009","article-title":"Serum IL-9, IL-17, and TGF-\u03b2 levels in subjects with diabetic kidney disease (CURES-134)","volume":"72","author":"Vasanthakumar","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.it.2020.11.003_bb0405","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.bbamcr.2013.07.001","article-title":"1,8-Cineol inhibits nuclear translocation of NF-\u03baB p65 and NF-\u03baB-dependent transcriptional activity","volume":"1833","author":"Greiner","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.it.2020.11.003_bb0410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fphar.2019.00178","article-title":"1,8-Cineole ameliorates LPS-induced vascular endothelium dysfunction in mice via PPAR-\u03b3 dependent regulation of NF-\u03baB","volume":"10","author":"Linghu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.it.2020.11.003_bb0415","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1007\/s10753-016-0394-3","article-title":"1,8-Cineol protect against influenza-virus-induced pneumonia in mice","volume":"39","author":"Li","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.it.2020.11.003_bb0420","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/rmed.2003.1432","article-title":"Anti-inflammatory activity of 1.8-cineol (eucalyptol) in bronchial asthma: a double-blind placebo-controlled trial","volume":"97","author":"Juergens","year":"2003","journal-title":"Respir. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0425","article-title":"Dexamethasone in hospitalized patients with Covid-19 \u2013 preliminary report","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0430","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","article-title":"Anakinra for severe forms of COVID-19: a cohort study","volume":"2","author":"Huet","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.it.2020.11.003_bb0435","article-title":"Convalescent plasma in the management of moderate Covid-19 in adults in India: open label Phase II multicentre randomised controlled trial (PLACID trial)","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.it.2020.11.003_bb0440","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1006\/jmbi.1993.1461","article-title":"Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid","volume":"232","author":"Bossart-Whitaker","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.it.2020.11.003_bb0445","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.it.2020.11.003_bb0450","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0455","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/156802610790725470","article-title":"Recent advances in targeting viral proteases for the discovery of novel antivirals","volume":"10","author":"Steuber","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.it.2020.11.003_bb0460","first-page":"171","article-title":"The treatment of Plasmodium falciparum malaria with a single dose antimalarial; a preliminary report of the use of hydroxychloroquine, 7-chloro-4(4-(N-ethyl-N-B-hydroxyethylamino)-1-methylbutylamino)-quinoline diphosphate","volume":"2","author":"Loughlin","year":"1952","journal-title":"Antibiot. Chemother. (Northfield)"},{"key":"10.1016\/j.it.2020.11.003_bb0465","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4269\/ajtmh.1955.4.221","article-title":"The treatment of malaria with hydroxychloroquine","volume":"4","author":"Hoekenga","year":"1955","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.it.2020.11.003_bb0470","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3899\/jrheum.120572","article-title":"The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus","volume":"40","author":"Akhavan","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.it.2020.11.003_bb0475","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/aid.1990.6.481","article-title":"Inhibition of human immunodeficiency virus infectivity by chloroquine","volume":"6","author":"Tsai","year":"1990","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.it.2020.11.003_bb0480","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1750-2659.2007.00027.x","article-title":"Chloroquine is effective against influenza A virus in vitro but not in vivo","volume":"1","author":"Vigerust","year":"2007","journal-title":"Influenza Other Respir. Viruses"},{"key":"10.1016\/j.it.2020.11.003_bb0485","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1099\/vir.0.017269-0","article-title":"Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection","volume":"91","author":"Freiberg","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0490","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1099\/jgv.0.000309","article-title":"Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model","volume":"96","author":"Dowall","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.it.2020.11.003_bb0495","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On chikungunya acute infection and chloroquine treatment","volume":"8","author":"De Lamballerie","year":"2008","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000785","article-title":"A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults","volume":"4","author":"Tricou","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0505","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41586-020-2558-4","article-title":"Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates","volume":"585","author":"Maisonnasse","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.it.2020.11.003_bb0510","doi-asserted-by":"crossref","first-page":"101738","DOI":"10.1016\/j.tmaid.2020.101738","article-title":"Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France","volume":"35","author":"Million","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0515","article-title":"Effect of hydroxychloroquine in hospitalized patients with COVID-19: preliminary results from a multi-centre, randomized, controlled trial","author":"Horby","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.it.2020.11.003_bb0520","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.it.2020.11.003_bb0525","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.it.2020.11.003_bb0530","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in nonhospitalized adults with early COVID-19","volume":"173","author":"Skipper","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0535","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.it.2020.11.003_bb0540","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2020.11.003_bb0545","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.it.2020.11.003_bb0550","doi-asserted-by":"crossref","first-page":"102468","DOI":"10.1016\/j.jaut.2020.102468","article-title":"The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19","volume":"111","author":"Perricone","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.it.2020.11.003_bb0555","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00281-006-0012-9","article-title":"Inhibition of IL-1, IL-6, and TNF-\u03b1 in immune-mediated inflammatory diseases","volume":"27","author":"M\u00f6ller","year":"2006","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.it.2020.11.003_bb0560","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex immune dysregulation in COVID-19 patients with severe respiratory failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.it.2020.11.003_bb0565","article-title":"Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients","author":"Hadjadj","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.it.2020.11.003_bb0570","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis","author":"Carvelli","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.it.2020.11.003_bb0575","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0580","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.it.2020.11.003_bb0585","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","article-title":"Tocilizumab in patients with severe COVID-19: a retrospective cohort study","volume":"2","author":"Guaraldi","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.it.2020.11.003_bb0590","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.it.2020.11.003_bb0595","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2020.11.003_bb0600","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/525263","article-title":"Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature","volume":"46","author":"Khanna","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0605","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.it.2020.11.003_bb0610","first-page":"OD10","article-title":"Intravenous immunoglobulin responsive persistent thrombocytopenia after dengue haemorrhagic fever","volume":"10","author":"Kumar","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.it.2020.11.003_bb0615","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.it.2020.11.003_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2020.05.006","article-title":"Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: a case series","volume":"548","author":"Mohtadi","year":"2020","journal-title":"Virology"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490620302611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490620302611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:06:08Z","timestamp":1761462368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490620302611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1471490620302611"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2020.11.003","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining Antivirals and Immunomodulators to Fight COVID-19","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2020.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}